Allianz’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06M Buy
7,072
+1,769
+33% +$537K 0.03% 229
2026
Q1
$1.13M Sell
5,303
-6,036
-53% -$1.35M 0.01% 280
2025
Q4
$1.94M Sell
11,339
-1,433
-11% -$223K 0.03% 209
2025
Q3
$1.71M Buy
12,772
+9,312
+269% +$986K 0.04% 198
2025
Q2
$337K Sell
3,460
-16,710
-83% -$1.33M 0.01% 270
2025
Q1
$1.47M Buy
20,170
+1,202
+6% +$94.7K 0.04% 206
2024
Q4
$1.37M Buy
+18,968
New +$1.44M 0.04% 204

Other funds holding LRCX

Allianz's LRCX Position: Q2 2026 in Review

Allianz increased its Lam Research (LRCX) stake by 33% in Q2 2026, buying an estimated $537K and bringing the position to 7,072 shares worth $3.06M. The position accounts for 0.03% of the portfolio, ranked #229.

Allianz first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Allianz held 7,072 shares of Lam Research worth $3.06M as of Q2 2026.
  • Allianz bought 1,769 Lam Research shares in Q2 2026, an estimated $537K.
  • Lam Research made up 0.03% of Allianz's portfolio in Q2 2026, its #229 holding.
  • Allianz first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.